12/5
04:07 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Dec 04 Filed by: Lurker Nancy
Low
Report
Form 4 EyePoint Pharmaceuticals For: Dec 04 Filed by: Lurker Nancy
12/4
10:25 am
eypt
Form 144 EyePoint Pharmaceuticals Filed by: Lurker Nancy
Medium
Report
Form 144 EyePoint Pharmaceuticals Filed by: Lurker Nancy
12/1
04:10 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Nov 26 Filed by: Lurker Nancy
Medium
Report
Form 4 EyePoint Pharmaceuticals For: Nov 26 Filed by: Lurker Nancy
11/28
01:23 pm
eypt
Form 144 EyePoint Pharmaceuticals Filed by: Lurker Nancy
Neutral
Report
Form 144 EyePoint Pharmaceuticals Filed by: Lurker Nancy
11/26
04:09 pm
eypt
Form 144 EyePoint Pharmaceuticals Filed by: Lurker Nancy
Low
Report
Form 144 EyePoint Pharmaceuticals Filed by: Lurker Nancy
11/19
07:05 am
eypt
Form 8-K EyePoint Pharmaceuticals For: Nov 19
Low
Report
Form 8-K EyePoint Pharmaceuticals For: Nov 19
11/13
09:07 am
eypt
Form SCHEDULE 13G/A EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
Medium
Report
Form SCHEDULE 13G/A EyePoint Pharmaceuticals Filed by: Adage Capital Management, L.P.
11/12
04:04 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Nov 11 Filed by: Ribeiro Ramiro
Medium
Report
Form 4 EyePoint Pharmaceuticals For: Nov 11 Filed by: Ribeiro Ramiro
11/12
06:56 am
eypt
Form 144 EyePoint Pharmaceuticals Filed by: Ribeiro Ramiro
Medium
Report
Form 144 EyePoint Pharmaceuticals Filed by: Ribeiro Ramiro
11/6
05:25 pm
eypt
Form 8-K EyePoint Pharmaceuticals For: Nov 06
Low
Report
Form 8-K EyePoint Pharmaceuticals For: Nov 06
11/6
05:23 pm
eypt
Form 424B5 EyePoint Pharmaceuticals
Low
Report
Form 424B5 EyePoint Pharmaceuticals
11/6
04:09 pm
eypt
Form 10-Q EyePoint Pharmaceuticals For: Sep 30
Low
Report
Form 10-Q EyePoint Pharmaceuticals For: Sep 30
11/5
07:05 am
eypt
Form 8-K EyePoint Pharmaceuticals For: Nov 05
High
Report
Form 8-K EyePoint Pharmaceuticals For: Nov 05
10/17
06:14 pm
eypt
Form SCHEDULE 13G/A EyePoint Pharmaceuticals Filed by: BlackRock, Inc.
Medium
Report
Form SCHEDULE 13G/A EyePoint Pharmaceuticals Filed by: BlackRock, Inc.
10/17
06:01 am
eypt
Form 8-K EyePoint Pharmaceuticals For: Oct 14
Low
Report
Form 8-K EyePoint Pharmaceuticals For: Oct 14
10/16
06:05 am
eypt
Form 424B5 EyePoint Pharmaceuticals
Low
Report
Form 424B5 EyePoint Pharmaceuticals
10/15
06:10 am
eypt
Form FWP EyePoint Pharmaceuticals Filed by: EyePoint Pharmaceuticals, Inc.
Medium
Report
Form FWP EyePoint Pharmaceuticals Filed by: EyePoint Pharmaceuticals, Inc.
10/14
05:20 pm
eypt
Form 424B5 EyePoint Pharmaceuticals
Medium
Report
Form 424B5 EyePoint Pharmaceuticals
10/14
04:22 pm
eypt
Form S-3ASR EyePoint Pharmaceuticals
High
Report
Form S-3ASR EyePoint Pharmaceuticals
10/14
04:09 pm
eypt
Form 8-K EyePoint Pharmaceuticals For: Oct 14
High
Report
Form 8-K EyePoint Pharmaceuticals For: Oct 14
9/22
04:11 pm
eypt
Form 4 EyePoint Pharmaceuticals For: Sep 19 Filed by: Elston George
Low
Report
Form 4 EyePoint Pharmaceuticals For: Sep 19 Filed by: Elston George